Shigella


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

Shigella

 [shĭ-gel´ah]
a genus of gram-negative, facultatively anaerobic, nonmotile, rod-shaped bacteria containing four species that are differentiated by biochemical reactions: S. dysente´riae (subgroup A), S. flex´�neri (subgroup B), S. boy´dii (subgroup C), and S. son´nei (subgroup D). Their normal habitat is the intestinal tract of humans and higher monkeys; all species cause dysentery.

shigella

 [shĭ-gel´ah]
any individual organism of the genus Shigella.

Shigella

(shē-gel'lă),
A genus of nonmotile, aerobic to facultatively anaerobic bacteria (family Enterobacteriaceae) containing gram-negative nonencapsulated rods. These organisms cannot use citrate as a sole source of carbon; their growth is inhibited by potassium cyanide and their metabolism is fermentative; they ferment glucose and other carbohydrates with the production of acid but not gas; lactose is ordinarily not fermented, although it is sometimes slowly attacked; the normal habitat is the intestinal tract of humans and of higher apes; all of the species produce dysentery. The type species is Shigella dysenteriae.
[Kiyoshi Shiga]

Shigella

/Shi·gel·la/ (shĭ-gel´ah) a genus of gram-negative bacteria (family Enterobacteriaceae) which cause dysentery. They are separated into four species on the basis of biochemical reactions: S. dysente´riae, S. flexne´ri, S. boy´dii, and S. son´nei.

shigella

/shi·gel·la/ (shĭ-gel´ah) pl. shigel´lae   an individual organism of the genus Shigella.

shigella

(shĭ-gĕl′ə)
n. pl. shi·gellae (-gĕl′ē) also shi·gellas
Any of various nonmotile, rod-shaped bacteria of the genus Shigella, which includes some species that cause dysentery.

Shigella

[shigel′ə]
Etymology: Kiyoshi Shiga, Japanese bacteriologist, 1870-1957
a genus of gram-negative pathogenic bacteria that causes gastroenteritis and bacterial dysentery, such as Shigella dysenteriae. It is also associated with hemolytic uremic syndromes. See also shigellosis.

Shigella

Microbiology A genus of gram-negative bacilli of the family Enterobacteriaceae, and major cause of bacterial dysentery

Shi·gel·la

(shē-gel'lă)
A genus of nonmotile, aerobic to facultatively anaerobic bacteria containing gram-negative, non-spore-forming rods. A major cause of dysentery.
[Kiyoshi Shiga]

Shiga,

Kiyoshi, Japanese bacteriologist, 1870-1957.
Shigella boydii - a species found in feces of symptomatic individuals.
Shigella dysenteriae - a species causing dysentery in humans and in monkeys. Synonym(s): Shiga bacillus; Shiga-Kruse bacillus
Shigella flexneri - a species found in the feces of symptomatic individuals and of convalescents or carriers; the most common cause of dysentery epidemics and sometimes of infantile gastroenteritis. Synonym(s): Flexner bacillus; paradysentery bacillus
Shigella sonnei - a species causing mild dysentery and also summer diarrhea in children. Synonym(s): Sonne bacillus
Shigella - a genus of nonmotile, aerobic to facultatively anaerobic bacteria (family Enterobacteriaceae), all of whose species produce dysentery.
Shiga bacillus - Synonym(s): Shigella dysenteriae
Shiga-Kruse bacillus - Synonym(s): Shigella dysenteriae
shigellosis - bacillary dysentery caused by bacteria of the genus Shigella.

Shi·gel·la

(shē-gel'lă)
Genus of nonmotile, aerobic to facultatively anaerobic bacteria with habitat in the intestinal tract of humans and of higher apes; all species produce dysentery.
[Kiyoshi Shiga]

Shigella

a genus of gram-negative rods in the family Enterobacteriaceae. There are four subgroups or species. The type species, S. dysenteriae, causes bacillary dysentery in humans and nonhuman primates. Other animals are resistant to infection, but organisms have been isolated from dogs without clinical signs.

shigella

pl. shigellae. See Escherichia coli Shigella.
References in periodicals archive ?
Antimicrobial susceptibility testing of Shigella isolates against ampicillin 10 [micro]g (AMP), trimethoprim/sulfamethoxazole 1.
GSK's (LON: GSK) Vaccines Institute for Global Health is working on a shigella vaccine, as is a partnership between Immuron Ltd (ASX: IMC) and the US Army's biomedical research lab Walter Reed Army of Research.
En general, la resistencia a las Quinolonas surge en forma espontanea por medio de mutaciones puntuales que resultan en los genes que codifican para la ADN Girasa y la Topoisomerasa IV, aunque otros puntos de mutacion han sido descritos (mutaciones en los genes que codifican para las porinas y bombas de eflujo, por ejemplo) y la aparicion reciente de un plasmido que media la resistencia a Quinolonas que produce la transferencia horizontal de la resistencia entre cepas, este tipo de resistencia es un problema en las infecciones por Salmonella y Shigella y las pruebas de susceptibilidad constituyen un coadyuvante importante para seleccionar el antibiotico apropiado (4)
Using a standard questionnaire, we interviewed persons infected with DSA or ciprofloxacin-resistant Shigella isolates, diagnosed during March 22, 2013-May 31, 2015; we abstracted antibiotic use data from medical charts.
9 against Shigella flexneri and Salmonella enterica strains at the concentration (32) Mg/ml according to Lewus et al.
The organism was identified as Shigella flexneri and confirmed with Shigella flexneri antiserum (Wellcome diagnostics).
When the increase in the proportion of Shigella infections occurring among homeless persons was recognized in December 2015, outbreak investigation questionnaires were updated to gather information about risk factors in this population.
Keywords: Shigella, Cancer, Drug resistance, Pakistan.
The report provides a snapshot of the global therapeutic landscape of Shigella Infections (Shigellosis)
Linearity and LOD of ETEC STIa, STIb, LT, and Shig-ipaH qRT-PCR assays were quantified using ETEC strains ETEC-STIa AF-ETEC727, ETEC-STIb AF-ETEC771, ETEC-LT AF-ETEC966 and Shigella flexneri strain ATCC12022, respectively.
USPRwire, Sun Aug 02 2015] GlobalData's clinical trial report, "Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015" provides data on the Shigella Infections (Shigellosis) clinical trial scenario.